Federal Agency Gives Green Light: How Relaxed Marijuana Laws Could Boost U.S. Stocks
Portfolio Pulse from Todd Harrison
The HHS has recommended rescheduling cannabis, which could lead to a 2-3X turn for U.S cannabis plant-touching securities. This news has already led to a 33.18% increase in AUM for the U.S cannabis ETF MSOS (NYSE:MSOS) and a 132.88% increase for MSOX (NYSE:MSOX). Other potential catalysts include SAFE Banking moving through the Senate and House of Representatives, uplisting to NYSE/NASDAQ, and CPG M&A. Companies like AYR Wellness (AYRWF) and 4Front Ventures (FFNTF) could benefit, as well as Tier1 companies like Verano (OTC: VRNOF), Green Thumb (OTC:GTBIF), Cresco (OTC:CRLBF), Curaleaf (OTC:CURLF) and Trulieve (OTC:TCNNF).
September 05, 2023 | 4:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AYR Wellness could benefit from the HHS's recommendation to reschedule cannabis.
The HHS's recommendation to reschedule cannabis could lead to increased interest in cannabis stocks, potentially benefiting companies like AYR Wellness.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Cresco could benefit from the HHS's recommendation to reschedule cannabis.
The HHS's recommendation to reschedule cannabis could lead to increased interest in cannabis stocks, potentially benefiting companies like Cresco.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Curaleaf could benefit from the HHS's recommendation to reschedule cannabis.
The HHS's recommendation to reschedule cannabis could lead to increased interest in cannabis stocks, potentially benefiting companies like Curaleaf.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
4Front Ventures could benefit from the HHS's recommendation to reschedule cannabis.
The HHS's recommendation to reschedule cannabis could lead to increased interest in cannabis stocks, potentially benefiting companies like 4Front Ventures.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Glass House Brand could benefit from the HHS's recommendation to reschedule cannabis.
The HHS's recommendation to reschedule cannabis could lead to increased interest in cannabis stocks, potentially benefiting companies like Glass House Brand.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Green Thumb could benefit from the HHS's recommendation to reschedule cannabis.
The HHS's recommendation to reschedule cannabis could lead to increased interest in cannabis stocks, potentially benefiting companies like Green Thumb.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
The U.S cannabis ETF MSOS has seen a 33.18% increase in AUM following the HHS's recommendation to reschedule cannabis.
The HHS's recommendation to reschedule cannabis has led to increased interest in cannabis stocks, leading to a significant increase in AUM for the U.S cannabis ETF MSOS.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
The U.S cannabis ETF MSOX has seen a 132.88% increase in AUM following the HHS's recommendation to reschedule cannabis.
The HHS's recommendation to reschedule cannabis has led to increased interest in cannabis stocks, leading to a significant increase in AUM for the U.S cannabis ETF MSOX.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Trulieve could benefit from the HHS's recommendation to reschedule cannabis.
The HHS's recommendation to reschedule cannabis could lead to increased interest in cannabis stocks, potentially benefiting companies like Trulieve.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
TerrAscend could benefit from the HHS's recommendation to reschedule cannabis.
The HHS's recommendation to reschedule cannabis could lead to increased interest in cannabis stocks, potentially benefiting companies like TerrAscend.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Verano could benefit from the HHS's recommendation to reschedule cannabis.
The HHS's recommendation to reschedule cannabis could lead to increased interest in cannabis stocks, potentially benefiting companies like Verano.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80